{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:31:23Z","timestamp":1790659883116,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Aims<\/jats:title>\n<jats:p>To assess the impact of the lockdown due to coronavirus disease 2019 (COVID-19) on key quality indicators for the treatment of ST-segment elevation myocardial infarction (STEMI) patients.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Data were obtained from 41 hospitals participating in the prospective Feedback Intervention and Treatment Times in ST-Elevation Myocardial Infarction (FITT-STEMI) study, including 15,800 patients treated for acute STEMI from January 2017 to the end of March 2020.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>There was a 12.6% decrease in the total number of STEMI patients treated at the peak of the pandemic in March 2020 as compared to the mean number treated in the March months of the preceding years. This was accompanied by a significant difference among the modes of admission to hospitals (<jats:italic>p<\/jats:italic>\u2009=\u20090.017) with a particular decline in intra-hospital infarctions and transfer patients from other hospitals, while the proportion of patients transported by emergency medical service (EMS) remained stable. In EMS-transported patients, predefined quality indicators, such as percentages of pre-hospital ECGs (both 97%, 95% CI\u2009=\u00a0\u2212\u00a02.2\u20132.7, <jats:italic>p<\/jats:italic>\u2009=\u20090.846), direct transports from the scene to the catheterization laboratory bypassing the emergency department (68% vs. 66%, 95% CI\u2009=\u00a0\u2212\u00a04.9\u20137.9, <jats:italic>p<\/jats:italic>\u2009=\u20090.641), and contact-to-balloon-times of less than or equal to 90\u00a0min (58.3% vs. 57.8%, 95%CI\u2009=\u00a0\u2212\u00a06.2\u20137.2, <jats:italic>p<\/jats:italic>\u2009=\u20090.879) were not significantly altered during the COVID-19 crisis, as was in-hospital mortality (9.2% vs. 8.5%, 95% CI\u2009=\u00a0\u2212\u00a03.2\u20134.5, <jats:italic>p<\/jats:italic>\u2009=\u20090.739).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Clinically important indicators for STEMI management were unaffected at the peak of COVID-19, suggesting that the pre-existing logistic structure in the regional STEMI networks preserved high-quality standards even when challenged by a threatening pandemic.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Clinical trial registration<\/jats:title>\n<jats:p>NCT00794001<\/jats:p>\n<\/jats:sec>","DOI":"10.1007\/s00392-020-01703-z","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T12:02:47Z","timestamp":1594900967000},"page":"1511-1521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Impact of COVID-19 outbreak on regional STEMI care in Germany"],"prefix":"10.1007","volume":"109","author":[{"given":"Karl Heinrich","family":"Scholz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Lengenfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Jeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Stefanow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Christian","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus Dieter","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"vom Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"von Beckerath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlheinz","family":"Seidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5347-7441","authenticated-orcid":false,"given":"Tim","family":"Friede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"1703_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H et al (2018) ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39:119\u2013177","journal-title":"Eur Heart J"},{"key":"1703_CR2","doi-asserted-by":"crossref","unstructured":"Scholz KH, Lengenfelder B, Jacobshagen C, Fleischmann C, Moehlis H, Olbrich HG et al (2020) Long-term effects of a standardized feedback-driven quality improvement program for timely reperfusion therapy in regional STEMI care networks. Eur Heart J Acute Cardiovasc Care (in print)","DOI":"10.1177\/2048872620907323"},{"key":"1703_CR3","doi-asserted-by":"crossref","unstructured":"Bonow RO, Fonarow GC, O'Gara PT, Yancy CW (2020) Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol (in print)","DOI":"10.1001\/jamacardio.2020.1105"},{"key":"1703_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.029","author":"JN Katz","year":"2020","unstructured":"Katz JN, Sinha SS, Alviar CL, Dudzinski DM, Gage A, Brusca SB et al (2020) COVID-19 and disruptive modifications to cardiac critical care delivery. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2020.04.029","journal-title":"J Am Coll Cardiol"},{"key":"1703_CR5","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","volume":"75","author":"E Driggin","year":"2020","unstructured":"Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G et al (2020) Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 75:2352\u20132371","journal-title":"J Am Coll Cardiol"},{"key":"1703_CR6","doi-asserted-by":"crossref","unstructured":"Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F et al (2020) Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol (in print)","DOI":"10.1001\/jamacardio.2020.0950"},{"key":"1703_CR7","doi-asserted-by":"crossref","unstructured":"Tam CF, Cheung KS, Lam S, Wong A, Yung A, Sze M et al (2020) Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes (in print)","DOI":"10.1161\/CIRCOUTCOMES.120.006631"},{"key":"1703_CR8","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1016\/j.jacc.2020.04.011","volume":"75","author":"S Garcia","year":"2020","unstructured":"Garcia S, Albaghdadi MS, Meraj PM, Schmidt C, Garberich R, Jaffer FA et al (2020) Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol 75:2871\u20132872","journal-title":"J Am Coll Cardiol"},{"key":"1703_CR9","doi-asserted-by":"crossref","unstructured":"Solomon MD, McNulty EJ, Rana JS, Leong TK, Lee C, Sung SH et al (2020) The Covid-19 pandemic and the incidence of acute myocardial infarction. N Engl J Med (in print)","DOI":"10.1056\/NEJMc2015630"},{"key":"1703_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01656-3","author":"M B\u00f6hm","year":"2020","unstructured":"B\u00f6hm M, Frey N, Giannitsis E, Sliwa K, Zeiher AM (2020) Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-020-01656-3","journal-title":"Clin Res Cardiol"},{"key":"1703_CR11","doi-asserted-by":"crossref","unstructured":"Enache B, Claessens YE, Boulay F, Dor V, Eker A, Civaia F et al (2020) Reduction in cardiovascular emergency admissions in Monaco during the COVID-19 pandemic. Clin Res Cardiol (in print)","DOI":"10.1007\/s00392-020-01687-w"},{"key":"1703_CR12","doi-asserted-by":"crossref","unstructured":"Rath D, Petersen-Uribe \u00c1, Avdiu A, Witzel K, Jaeger P, Zdanyte M et al (2020) Impaired cardiac function is associated with mortality in patients with acute COVID-19 infection. Clin Res Cardiol (in print)","DOI":"10.1007\/s00392-020-01683-0"},{"key":"1703_CR13","doi-asserted-by":"crossref","unstructured":"Rattka M, Baumhardt M, Dreyhaupt J, Rothenbacher D, Thiessen K, Markovic S, et al (2020) 31 days of COVID-19-cardiac events during restriction of public life-a comparative study. Clin Res Cardiol (in print)","DOI":"10.2139\/ssrn.3594561"},{"key":"1703_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01676-z","author":"S Settelmeier","year":"2020","unstructured":"Settelmeier S, Rassaf T, Giannitsis E, M\u00fcnzel T, Breuckmann F (2020) Capacity changes in German certified chest pain units during COVID-19 outbreak response. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-020-01676-z","journal-title":"Clin Res Cardiol"},{"key":"1703_CR15","doi-asserted-by":"crossref","unstructured":"Tsioufis K, Chrysohoou C, Kariori M, Leontsinis I, Dalakouras I, Papanikolaou A, et al (2020) The mystery of \"missing\" visits in an emergency cardiology department, in the era of COVID-19.; a time-series analysis in a tertiary Greek General Hospital. Clin Res Cardiol (in print)","DOI":"10.1007\/s00392-020-01716-8"},{"key":"1703_CR16","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/eurheartj\/ehy069","volume":"39","author":"W Wijns","year":"2018","unstructured":"Wijns W, Naber CK (2018) Reperfusion delay in patients with high-risk ST-segment elevation myocardial infarction: every minute counts, much more than suspected. Eur Heart J 39:1075\u20131077","journal-title":"Eur Heart J"},{"key":"1703_CR17","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jcin.2012.04.012","volume":"5","author":"KH Scholz","year":"2012","unstructured":"Scholz KH, Maier SK, Jung J, Fleischmann C, Werner GS, Olbrich HG et al (2012) Reduction in treatment times through formalized data feedback: results from a prospective multicenter study of ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 5:848\u2013857","journal-title":"JACC Cardiovasc Interv"},{"key":"1703_CR18","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/eurheartj\/ehy004","volume":"39","author":"KH Scholz","year":"2018","unstructured":"Scholz KH, Maier SKG, Maier LS, Lengenfelder B, Jacobshagen C, Jung J et al (2018) Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J 39:1065\u20131074","journal-title":"Eur Heart J"},{"key":"1703_CR19","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1161\/01.CIR.102.17.2031","volume":"102","author":"DA Morrow","year":"2000","unstructured":"Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA et al (2000) TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102:2031\u20132037","journal-title":"Circulation"},{"key":"1703_CR20","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Leor O, Cid-\u00c1lvarez B, Ojeda S, Mart\u00edn-Moreiras J, Ram\u00f3n Rumoroso JR, L\u00f3pez-Palop R et al (2020) Impacto de la pandemia de COVID-19 sobre la actividad asistencial en cardiolog\u00eda intervencionista en Espa\u00f1a. REC Interv Cardiol (in print)","DOI":"10.24875\/RECIC.M20000120"},{"key":"1703_CR21","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1161\/CIRCULATIONAHA.120.047122","volume":"141","author":"MJ Daniels","year":"2020","unstructured":"Daniels MJ, Cohen MG, Bavry AA, Kumbhani DJ (2020) Reperfusion of ST-segment-elevation myocardial infarction in the COVID-19 era\u2014Business as usual? Circulation 141:1948\u20131950","journal-title":"Circulation"},{"key":"1703_CR22","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.jacc.2020.03.021","volume":"75","author":"FGP Welt","year":"2020","unstructured":"Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW et al (2020) American College of Cardiology\u2019s Interventional Council and the Society of Cardiovascular Angiography and Intervention. Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from ACC's Interventional Council and SCAI. J Am Coll Cardiol 75:2372\u20132375","journal-title":"J Am Coll Cardiol"},{"key":"1703_CR23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2010418","author":"E Baldi","year":"2020","unstructured":"Baldi E, Sechi GM, Mare C, Canevari F, Brancaglione A, Primi R et al (2020) Out-of-hospital cardiac arrest during the Covid-19 outbreak in Italy. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMc2010418","journal-title":"N Engl J Med"},{"issue":"S1","key":"1703_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/2048872618813907","volume":"9","author":"KH Scholz","year":"2020","unstructured":"Scholz KH, Friede T, Meyer T, Jacobshagen C, Lengenfelder B, Jung J et al (2020) Prognostic significance of emergency department bypass in stable and unstable patients with ST-segment elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care 9(S1):34\u201344","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"1703_CR25","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1093\/eurheartj\/ehaa258","volume":"41","author":"ZC Jing","year":"2020","unstructured":"Jing ZC, Zhu HD, Yan XW, Chai WZ, Zhang S (2020) Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak. Eur Heart J 41:1791\u20131794","journal-title":"Eur Heart J"},{"key":"1703_CR26","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00134-020-05993-9","volume":"46","author":"J Zeng","year":"2020","unstructured":"Zeng J, Huang J, Pan L (2020) How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People\u2019s Hospital. Intensive Care Med 46:1111\u20131113","journal-title":"Intensive Care Med"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-020-01703-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-020-01703-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-020-01703-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T23:46:59Z","timestamp":1626392819000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-020-01703-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1703"],"URL":"https:\/\/doi.org\/10.1007\/s00392-020-01703-z","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"15 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Tim Friede reports personal fees from Novartis, Bayer, Janssen, SGS, Roche, Boehringer Ingelheim, Daiichi-Sankyo, Galapagos, Penumbra, Parexel, Vifor, BiosenseWebster, CSL Behring, Fresenius Kabi, Coherex Medical, and LivaNova; all outside the submitted work. All other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}